semaglutide and cardiovascular outcomes in obesity without diabetes journal club SELECT Trial Semaglutide and Cardiovascular Outcomes in

Many patients admitted for acute myocardial infarction have type 2 diabetes, and they are more likely to die during the acute episode or in follow-up [1]

& Cashmere, K

Canner PL, Berge KG, Wenger NK, Stamler J, Friedman L, Prineas RJ, Friedewald W

Check date values in: |accessdate= (help) "SAXENDA prescribing information" (PDF)

This autoimmune condition, where the immune system attacks the thyroid gland, is increasingly prevalent, especially among women

In addition, lessons learned from type 2 diabetes with regard to the beneficial effects of certain agents on, for example, body weight and cardiorenal risk may also prove relevant in type 1 diabetes